Skip to main content

Table 2 Baseline characteristics of subjects without (AdipoR2) and with the AdipoR2 SNP cluster (AdipoR2-SNP). Data are presented as median and interquartile range.

From: Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome

 

AdipoR2

AdipoR2-SNP

p

n (female/male)

15 (10/5)

5 (3/2)

 

Age [years]

34 (25–44)

41 (27–53)

0.50

BMI [kg/m2]

30.7 (29.4–34.5)

31.3 (27.3–35.7)

0.87

Waist to hip ratio

0.89 (0.84–0.93)

0.84 (0.78–0.93)

0.50

Fasting plasma glucose [mg/dl]

105 (100–107)

103 (91–113)

0.74

HOMA-index

3.26 (2.44–4.55)

3.43 (2.74–4.31)

0.93

Fasting total cholesterol [mg/dl]

208 (176–229)

188 (150–227)

0.67

Fasting HDL-cholesterol [mg/dl]

52 (40–60)

57 (51–65)

0.31

Fasting LDL-cholesterol [mg/dl]

114 (85–147)

122 (71–142)

0.87

Fasting triglycerides [mg/dl]

176 (118–285)

83 (72–156)

0.01

Adiponectin [ng/ml]

2026 (1477–2470)

3707 (2459–5194)

0.07

  1. HOMA: homeostasis model assessment